These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16728361

  • 1. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A, Marzouk I, El-Shayeb A, Wali Y.
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [Abstract] [Full Text] [Related]

  • 2. Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement.
    Katz K, Tamary H, Lahav J, Soudry M, Cohen IJ.
    Bull Hosp Jt Dis; 1999; 58(4):188-90. PubMed ID: 10711366
    [Abstract] [Full Text] [Related]

  • 3. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [Abstract] [Full Text] [Related]

  • 4. Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy.
    Hollak CE, Levi M, Berends F, Aerts JM, van Oers MH.
    Br J Haematol; 1997 Mar; 96(3):470-6. PubMed ID: 9054650
    [Abstract] [Full Text] [Related]

  • 5. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
    Kauli R, Zaizov R, Lazar L, Pertzelan A, Laron Z, Galatzer A, Phillip M, Yaniv Y, Cohen IJ.
    Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
    [Abstract] [Full Text] [Related]

  • 6. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 7. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, Ferreira P.
    Blood Cells Mol Dis; 2007 Apr 20; 38(3):287-93. PubMed ID: 17196853
    [Abstract] [Full Text] [Related]

  • 8. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
    Ghosh K, Mota L, Shetty S, Kulkarni B.
    Blood Coagul Fibrinolysis; 2008 Sep 20; 19(6):577-80. PubMed ID: 18685441
    [Abstract] [Full Text] [Related]

  • 9. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
    Charrow J, Dulisse B, Grabowski GA, Weinreb NJ.
    Clin Genet; 2007 Mar 20; 71(3):205-11. PubMed ID: 17309642
    [Abstract] [Full Text] [Related]

  • 10. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP.
    Pathol Biol (Paris); 2004 Jul 20; 52(6):343-50. PubMed ID: 15261378
    [Abstract] [Full Text] [Related]

  • 11. Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy.
    Mitrovic M, Sumarac Z, Antic D, Bogdanovic A, Elezovic I, Vukosavljevic D, Ignjatovic S, Majkic-Singh N, Suvajdzic N.
    Blood Cells Mol Dis; 2012 Jun 15; 49(1):58-9. PubMed ID: 22459893
    [No Abstract] [Full Text] [Related]

  • 12. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
    Kawahara S, Kato A, Oshimi K, Ida H.
    Rinsho Ketsueki; 2008 May 15; 49(5):335-9. PubMed ID: 18572811
    [Abstract] [Full Text] [Related]

  • 13. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A, Gort L, Díaz-Font A, Montfort M, Santamaría R, Cidrás M, Grinberg D, Vilageliu L.
    Blood Cells Mol Dis; 2005 May 15; 35(2):253-8. PubMed ID: 15967693
    [Abstract] [Full Text] [Related]

  • 14. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
    Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R.
    J Pediatr; 2007 Aug 15; 151(2):197-201. PubMed ID: 17643778
    [Abstract] [Full Text] [Related]

  • 15. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding.
    Spectre G, Roth B, Ronen G, Rosengarten D, Elstein D, Zimran A, Varon D, Revel-Vilk S.
    Br J Haematol; 2011 May 15; 153(3):372-8. PubMed ID: 21401572
    [Abstract] [Full Text] [Related]

  • 16. [Gaucher's disease ].
    Belmatoug N, Caubel I, Stirnemann J, Billette de Villemeur T.
    J Soc Biol; 2002 May 15; 196(2):141-9. PubMed ID: 12360743
    [Abstract] [Full Text] [Related]

  • 17. Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease.
    Mitrovic M, Antic D, Elezovic I, Janic D, Miljic P, Sumarac Z, Nikolic T, Suvajdzic N.
    Platelets; 2012 May 15; 23(2):143-9. PubMed ID: 21767238
    [Abstract] [Full Text] [Related]

  • 18. Gaucher disease: from fundamental research to effective therapeutic interventions.
    de Fost M, Aerts JM, Hollak CE.
    Neth J Med; 2003 Jan 15; 61(1):3-8. PubMed ID: 12688562
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
    Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S.
    Blood Cells Mol Dis; 2007 Jan 15; 39(3):348-52. PubMed ID: 17689991
    [Abstract] [Full Text] [Related]

  • 20. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ, Cabrera-Salazar MA, Echeverri OY, Miller G, Barrera LA.
    Mol Genet Metab; 2005 Dec 15; 86(4):466-72. PubMed ID: 16185907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.